Not applicableAvailableNCT01590680What this trial is testingExpanded Access Protocol Using 131I-MIBGWho this might be right forNeuroblastomaPheochromocytomaParaganglioma Jubilant DraxImage Inc.
Not applicableStudy completedNCT01850888What this trial is testingMIBG for Refractory Neuroblastoma and PheochromocytomaWho this might be right forRelapsed NeuroblastomaMetastatic Pheochromocytoma Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284774What this trial is testingTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment TrialWho this might be right forMalignant Solid NeoplasmRecurrent Adrenal Gland PheochromocytomaRecurrent Ectomesenchymoma+38 more National Cancer Institute (NCI) 5
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Not applicableApproved For MarketingNCT02961491What this trial is testingExpanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/ParagangliomaWho this might be right forPheochromocytomaParaganglioma Molecular Insight Pharmaceuticals, Inc.
Not applicableAvailableNCT03015844What this trial is testingA Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic PheochromocytomaWho this might be right forNeuroblastomaPheochromocytoma Northwell Health
Not applicableNo Longer AvailableNCT03649438What this trial is testing131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory NeuroblastomaWho this might be right forRelapsed NeuroblastomaMetastatic Pheochromocytoma University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Testing effectiveness (Phase 2)UnknownNCT00874614What this trial is testingA Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/ParagangliomaWho this might be right forPheochromocytomaParaganglioma Molecular Insight Pharmaceuticals, Inc. 74
Not applicableNo Longer AvailableNCT01838187What this trial is testingExpanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or ParagangliomaWho this might be right forNeuroblastomaPheochromocytomaParaganglioma Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)Looking for participantsNCT00107289What this trial is testingIodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or ParagangliomaWho this might be right forNeuroblastomaPheochromocytoma Memorial Sloan Kettering Cancer Center 200
Not applicableWithdrawnNCT04770831What this trial is testingPatients Who Receive 131 I-MIBGWho this might be right forBrain and Nervous System Wake Forest University Health Sciences
Early research (Phase 1)Ended earlyNCT00002947What this trial is testingIndium In 111 Pentetreotide in Treating Patients With Refractory CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more Yale University 35
Not applicableAvailableNCT01163383What this trial is testing131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access ProtocolWho this might be right forNeuroblastomaChildhood Metastatic Pheochromocytoma John Maris